Where does Inolex Investment Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inolex Investment Corporation ranks #16,110 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inolex Investment Corporation hold?

Inolex Investment Corporation holds 18 US utility patents granted between 2017 and 2025, spanning 11 technology areas.

What is Inolex Investment Corporation's Innovation Score?

Inolex Investment Corporation has an Innovation Score of 38.7 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Inolex Investment Corporation focus on?

Inolex Investment Corporation's top technology area is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations) with 16 patents, ranking #71 of 1,001 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Inolex Investment Corporation's patent grant rate increasing or decreasing?

Inolex Investment Corporation's recent grant velocity is +175% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Inolex Investment Corporation's patents?

Inolex Investment Corporation's patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Inolex Investment Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Inolex Investment Corporation

USPTO PatentsView assignee record - 18 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inolex ranks #16,110 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 11 technology areas.

#16,110
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 21.0
avg claims per patent: +175%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16110 · US Corporation #16,110 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,110/49,997
PHOTO-FINISH IFGCure Holdings
CPC-FOCUS A61Q · 11 areas
INNOV-THIN 38.7/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +175% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: IFGCure Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inolex’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (26%) Velocity 4.2 pts (11%) Breadth 11.7 pts (30%) Claim depth 12.6 pts (33%)

Qualcomm Incorporated · highest

85
Inolex Investment · this assignee

39
3D Lighting… · lowest

7

What this shows Inolex's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Inolex?

Each dot is one of Inolex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inolex’s own 21.0 claims/patent is ABOVE the 9.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Inolex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inolex's grants concentrate

Inolex Investment Corporation is a focused PatentsView assignee: 11 CPC subclasses with 88.9% of grants classified under A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2020. By volume, Inolex sits between IFGCure Holdings, LLC and Inventage LAB Inc..

Inolex's three-year grant acceleration

Inolex Investment Corporation shows 5 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ifgcure Holdings

18
Includefitness

18
Indian Institute…

18
Innoscience (Suzh…

18
Intermec

18
Intradin (Huzhou)…

18
Invent Umwelt-und…

18
Inventage LAB

18
Inolex Investment ◀

18

What this shows Inolex holds 18 patents at rank #16,098, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inolex

By rank, the assignees closest to #16,098 in granted patent volume.

Leaders in A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations)

Other assignees with the most granted patents in Inolex's primary technology class.

Inolex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Inolex Investment Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	11.1%
2019	2	11.1%
2020	1	5.6%
2021	5	27.8%
2022	3	16.7%
2023	1	5.6%
2024	1	5.6%
2025partial year	3	16.7%

Which technologies does Inolex Investment Corporation patent most?

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

C07C - Acyclic OR Carbocyclic Compounds 6

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

A01P - Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations 2

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Inolex Investment Corporation's patent record in context - here's where to go next.

Inolex Investment Corporation's lead technology class is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations), 88.9% of its portfolio - see every assignee active in that class. Explore A61Q
Ranked #16,110 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inolex Investment Corporation against IFGCure Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.